Full-Time

Oncology Account Executive

Confirmed live in the last 24 hours

Hologic

Hologic

5,001-10,000 employees

Develops medical devices and diagnostic products

Compensation Overview

$220k - $230k/yr

+ Commission

Senior

Washington, DC, USA

Hybrid

50% travel required within sales region, as well as corporate meetings, trade shows and special events.

Category
Field Sales
Sales & Account Management
Requirements
  • Bachelor’s Degree (Science degree preferred)
  • 5+ years of diagnostics or medical sales experience; oncology preferred
  • Valid driver’s license required
  • 50% travel required within sales region, as well as corporate meetings, trade shows and special events
Responsibilities
  • Develop and implement an effective territory business plan
  • Target top academic medical centers and community-based oncology practices
  • Nurture relationships with key customers
  • Deliver effective scientific presentations to customers
Desired Qualifications
  • Strong understanding of life sciences and molecular diagnostics, specifically for breast and general oncology

Hologic focuses on improving health through early detection and treatment solutions in the medical technology field. The company develops and sells medical devices and diagnostic products, particularly in areas like breast and skeletal health, GYN surgical products, and medical aesthetics. Their products work by providing reliable diagnostic tools that help healthcare providers identify diseases early and treat them effectively. Hologic stands out from competitors by its strong commitment to quality and innovation, ensuring that their solutions meet critical health needs. The goal of Hologic is to enhance health and well-being globally by offering advanced medical technologies that support healthcare professionals and improve patient outcomes.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Santa Clara, null

Founded

1985

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven diagnostic tools align with Hologic's focus on innovation and accuracy.
  • Growing women's health diagnostics market offers opportunities for Hologic's products.
  • Rising demand for minimally invasive procedures benefits Hologic's GYN surgical products.

What critics are saying

  • Potential acquisition by TPG and Blackstone may lead to strategic shifts.
  • Closure of Connecticut plant and layoffs could impact operational efficiency.
  • Volatility in stock trading may affect investor confidence.

What makes Hologic unique

  • Hologic specializes in AI-powered mammography technology for early disease detection.
  • The company has a strong global presence in key healthcare markets.
  • Hologic's diverse product range includes breast health, diagnostics, and GYN surgical products.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Performance Bonus

Company News

Business Insider
May 27th, 2025
TPG, Blackstone $16B Offer for Hologic

TPG and Blackstone have proposed a deal to take Hologic private, valuing the company at $16.3-$16.7 billion, including debt, according to the Financial Times. Although Hologic recently rejected the non-binding offer, there remains a possibility for renewed discussions. The news also mentions Hologic's trading halt due to volatility, and recent price target adjustments by Stephens and Morgan Stanley.

The ICE Community
Apr 25th, 2025
New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI

Hologic Inc. will have a strong presence at the Society of Breast Imaging (SBI) Annual Symposium in Colorado Springs, Colorado, including the presentation of pivotal new research conducted by a top-tier healthcare facility focused on the company's AI-driven mammography technology.

Business Wire
Feb 25th, 2025
Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference

Hologic to webcast presentation at the Raymond James 46th Annual Institutional Investors Conference.

ETF Daily News
Jan 11th, 2025
Diversified Trust Co Makes New Investment in Hologic, Inc. (NASDAQ:HOLX)

Diversified Trust Co makes new investment in Hologic, Inc. (NASDAQ:HOLX).

WB Journal
Dec 23rd, 2024
Results: How did WBJ do with 2024's bold predictions?

The industry is still right-sizing itself after its rapid expansion in the wake of COVID-19, and a few companies laid off dozens of employees: Marlborough-based Sumitomo Pharma America laid off 53, and Marlborough-based Hologic is closing a plant in Connecticut, resulting in 86 layoffs.